Use of metformin and orlistat for the treatment or prevention of obesity

Details for Australian Patent Application No. 2005226847 (hide)

Owner Fournier Laboratories Ireland Limited

Inventors Edgar, Alan; Junien, Jean-Louis

Agent FB Rice

Pub. Number AU-B-2005226847

PCT Pub. Number WO2005/092311

Priority 04300137.9 12.03.04 EP

Filing date 11 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 3 April 2008

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/092311 Priority application(s): WO2005/092311

3 April 2008 Application Accepted

  Published as AU-B-2005226847

31 July 2008 Standard Patent Sealed

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226856-A case for a cigarette packet

2005226844-Conjugates of hydroxyalkyl starch and a protein